Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
2.
Respirology ; 13(1): 97-102, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18197917

RESUMO

BACKGROUND AND OBJECTIVE: To quantify the CXR using a profusion of small lung opacities score in patients with pulmonary exacerbation of sarcoidosis. In particular, the study sought to determine whether the CXR changes were a reliable indicator of disease exacerbation. METHODS: The study recruited patients with an exacerbation of pulmonary sarcoidosis, who were attending a university medical centre sarcoidosis clinic. Pulmonary exacerbation was defined as worsening pulmonary symptoms, thought to be related to sarcoidosis, that responded to an increase in corticosteroid dose. A subset of patients were identified who met the criteria of spirometric decline of >or=10% in FVC or FEV(1) from the previous (baseline) visit. Patients required a baseline CXR and spirometry and had CXR and spirometry performed at the initial assessment. Two International Labour Organisation B readers interpreted the CXR in a blinded manner. RESULTS: All study patients (n = 36) were African American; there were 24 patients in the 'spirometric decline' subgroup. Agreement between the B readers was moderate (kappa = 0.54, P < 0.01). The mean profusion score increased, or worsened by 1.38 points (SD = 3.60, P = 0.008) for the exacerbation group while the 'spirometric decline' group worsened by an average of 1.80 points (SD = 3.81, P = 0.031). There was too much variation for a cut-off to be identified that would reliably diagnose exacerbations. There was no significant correlation between FVC or FEV(1) and profusion score. CONCLUSIONS: The CXR International Labour Organisation profusion score is not a reliable test to detect pulmonary exacerbations of sarcoidosis. However, a CXR may be useful to exclude other diagnostic possibilities.


Assuntos
Radiografia Pulmonar de Massa , Sarcoidose Pulmonar/diagnóstico por imagem , Adulto , Estudos de Coortes , Feminino , Glucocorticoides/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Testes de Função Respiratória , Sarcoidose Pulmonar/complicações , Sarcoidose Pulmonar/terapia , Sensibilidade e Especificidade , Índice de Gravidade de Doença
3.
Chest ; 143(5): 1414-1421, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23117277

RESUMO

BACKGROUND: Pulmonary aspergillomas may cause life-threatening hemoptysis. The treatment of this condition is problematic because poor pulmonary function often precludes definitive surgical resection. METHODS: We retrospectively reviewed all patients hospitalized at our institution for hemoptysis associated with an aspergilloma over an 8-year period and who underwent percutaneous intracavitary instillation of amphotericin B (ICAB). ICAB consisted of catheter placement into the aspergilloma cavity with subsequent instillation of 50 mg amphotericin B in 20 mL 5% dextrose solution daily for 10 days. RESULTS: ICAB was attempted for 23 distinct episodes of severe hemoptysis in 20 individual patients. Catheter placement was successful in 21 of the 23 episodes (91%), and of these, ICAB instillation was successfully completed in 20 episodes (95%). In these 20 episodes, hemoptysis ceased by hospital discharge in 17 of 20 patients (85%) and in all 18 who survived until a follow-up visit 1-month after treatment. Pneumothorax occurred in six of 23 (26%) catheter placement attempts without long-term complications. Recurrence of serious hemoptysis occurred after six of 18 episodes for which follow-up was available. Potential risk factors associated with severe, recurrent hemoptysis were a size increase or reappearance of the aspergilloma on a chest CT scan (P = .001), bleeding diathesis (P = .08), and lack of bronchial artery embolization during index hospitalization (P = .07). CONCLUSIONS: Our data suggest that ICAB is an effective short-term treatment to control severe hemoptysis caused by pulmonary aspergilloma. The long-term benefit of this procedure is unknown. We identified several potential risk factors for recurrent hemoptysis after ICAB that could be examined prospectively in future trials.


Assuntos
Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Hemoptise/etiologia , Aspergilose Pulmonar/complicações , Aspergilose Pulmonar/tratamento farmacológico , Índice de Gravidade de Doença , Adulto , Idoso , Anfotericina B/administração & dosagem , Antifúngicos/administração & dosagem , Aspergillus/isolamento & purificação , Catéteres , Feminino , Humanos , Instilação de Medicamentos , Estudos Longitudinais , Pulmão/microbiologia , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Risco , Prevenção Secundária , Resultado do Tratamento
4.
J Pediatr Surg ; 45(5): 1050-2, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20438953

RESUMO

Rectal prolapse is a relatively common, benign condition in the pediatric population. Conservative management usually results in resolution of the problem. Persistent rectal prolapse with chronic constipation suggests more serious underlying pathologic condition that may be challenging to diagnose. We present a case of severe recurrent rectal prolapse with chronic constipation in a 13-year-old boy. Using video defecography, an unusual radiographic modality in children, a functional sigmoid obstruction was observed that was not found on more routine imaging studies. Laparoscopic sigmoidectomy provided an excellent outcome in this patient who previously had a lifestyle-limiting, chronic condition.


Assuntos
Constipação Intestinal/etiologia , Defecografia/instrumentação , Obstrução Intestinal/diagnóstico por imagem , Prolapso Retal/etiologia , Doenças do Colo Sigmoide/diagnóstico por imagem , Adolescente , Doença Crônica , Constipação Intestinal/cirurgia , Humanos , Obstrução Intestinal/complicações , Obstrução Intestinal/cirurgia , Masculino , Prolapso Retal/cirurgia , Doenças do Colo Sigmoide/complicações , Doenças do Colo Sigmoide/cirurgia , Gravação em Vídeo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA